N348I in HIV-1 Reverse Transcriptase Decreases Susceptibility to Tenofovir and Etravirine in Combination with Other Resistance Mutations

Lignende værker

• N348I in HIV-1 Reverse Transcriptase Counteracts the Synergy Between Zidovudine and Nevirapine
  af: YAP, Soo Huey, et al.
  Udgivet: (2012)
• N348I in Reverse Transcriptase Provides a Genetic Pathway for HIV-1 to Select TAMs and Mutations Antagonistic to TAMs
  af: Radzio, Jessica, et al.
  Udgivet: (2010)
• Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer
  af: Wapling, Johanna, et al.
  Udgivet: (2005)
• Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase
  af: Radzio, Jessica, et al.
  Udgivet: (2011)
• Mechanisms of inhibition of HIV replication by nonnucleoside reverse transcriptase inhibitors
  af: Sluis-Cremer, Nicolas, et al.
  Udgivet: (2008)